In this context, we observed that the combined treatment of pasakbumin A and the anti-TB drug RMP resulted in increased intracellular LC3 distribution and phosphorylated ERK1/2 and IκBα in Mtb-infected cells compared to cells infected Mtb alone. This evidence concerns the gene MAPK3 and tuberculosis.